Myriad Genetics, Inc. (NASDAQ:MYGN)

CAPS Rating: 5 out of 5

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

Recs

3
Player Avatar chessmatetrader (< 20) Submitted: 7/20/2010 9:27:49 AM : Underperform Start Price: $15.25 MYGN Score: -42.63

Why not???????????????????????

Report this Post Reply

Featured Broker Partners


Advertisement